COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

News Releases

News Releases

Date
Title
Document
May 29, 2020
BioDelivery Sciences to Present at Two Upcoming Investor Conferences
PDF Version
May 11, 2020
BioDelivery Sciences Appoints Jeff Bailey Interim CEO
PDF Version
May 7, 2020
BioDelivery Sciences Reports Strong Q1 2020 Results
PDF Version
April 28, 2020
BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020
PDF Version
March 12, 2020
BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results
PDF Version
March 9, 2020
BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors
PDF Version
February 27, 2020
BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meeting
PDF Version
February 20, 2020
BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
PDF Version
January 13, 2020
BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic
PDF Version
January 6, 2020
BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development
PDF Version

Investor Presentation

More information is coming soon.


Upcoming Events

More events are coming soon.

Stay Connected

Stay up to date on the latest news

Get started now
July 1, 2020 /
Data provided by West LLC. Minimum 15 minutes delayed.